ALTURiX is pleased to announce its support for the NACinCOVID Study which is being coordinated by the Cambridge Health Alliance (CHA) based in Cambridge, Massachusetts.
We look forward to the results of the study later this year.
Our new programme dedicated to highlighting the value that our products bring to the NHS, prescribers, and patients.
